Prothena Corporation Company Profile, Contacts & Intelligence

Biotechnology ResearchDocklands, United States155 employeesFounded 2012
3 contacts with email or phone data3 with email data3 with phone data
View verified contacts Compare competitors
Employees
155
Company source estimate
Reachable Contacts
3
Visible contacts with email or phone data
Contacts With Email
3
3 of 4 visible contacts
Departments
6
Mapped contact coverage

Prothena Corporation Overview

Prothena is a late-stage clinical biotechnology company with expertise in protein dysregulation and a diverse pipeline of novel investigational therapies for neurodegenerative and rare peripheral amyloid diseases. We are committed to developing novel and transformative medicines to create a better future for people in critical need of new treatment options. Our product portfolio is designed to make a significant impact on neurodegenerative and rare peripheral amyloid diseases, which affect millions of people and their families worldwide. We leverage insights around neurological dysfunction and the biology of misfolded proteins to develop novel therapeutic solutions that directly target pathogenic proteins in order to change the course of devastating diseases. At Prothena, our success is driven by our people. We are dedicated to attracting individuals who share our vision to improve human health by putting patients first. Our shared humanity drives a passionate and unwavering commitment to apply high scientific rigor toward developing innovative new therapies for patients. We have ambitious goals and take every aspect of our mission seriously, while enjoying the journey. Our values connect us – you will see and feel them come to life in all we do – together.

Headquarters
Docklands, United States
Website
prothena.com
Industry
Biotechnology Research
Founded
2012
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Phone Number
Available in AeroLeads
Company Email
Available in AeroLeads
in protein dysregulation and a diverse pipeline of novel investigational therapies for neurodegenerative and rare peripheral amyloid diseases.

Prothena Corporation Contact Intelligence

See which contact channels and departments are represented in the visible AeroLeads data.

3 contacts with contact data
3 with email data and 3 with phone data in the visible sample.
6 departments represented
Visible contacts with email or phone data are mapped to these departments.
7 company-domain emails
Visible contacts using Prothena Corporation's company email domain.
General
6
Healthcare
2
HR
2
Operations
2
Executive
2
Finance
1

Prothena Corporation People & Org Chart Preview

Sample people records show job titles and whether email or phone data is available without exposing raw contact details.

T
Tran N.
P
Paula Cobb
Biotech Exec and Board Member
EP
M
Mark C. Johnson, Cfa
EP
K
Kevin Mccarl
Global Biotech Commercialization Leader
EP

Prothena Corporation Workforce Composition

Seniority breakdown across 27 visible profiles.

Director
9
Individual contributor
9
Manager
6
Executive
1
Senior / Lead
1
Associate / junior
1

Prothena Corporation Technology & Talent

Technology-related job titles represented in the visible people data.

Cloud / infrastructure
1
Data / AI
1

Compare Similar Companies to Prothena Corporation

Explore companies in related markets and compare their industry and employee estimates.

Company Industry / match Employee estimate Page
AbbVie Pharmaceutical Manufacturing 57.01K View company
Amgen Biotechnology Research 35.77K View company
Gilead Sciences Biotechnology Research 14.65K View company
Vertex Pharmaceuticals Biotechnology Research 6.09K View company
BioMarin Pharmaceutical Inc. Biotechnology Research 3.12K View company
Alnylam Pharmaceuticals Biotechnology Research 2.58K View company
Cytokinetics Biotechnology Research 634 View company
Denali Therapeutics Biotechnology Research 549 View company
Crinetics Pharmaceuticals Biotechnology Research 510 View company
Prothena Biosciences Inc. Research 27 View company